Cian Healthcare Ltd

Cian Healthcare Limited has announced the closure of its trading window for Designated Persons and their immediate relatives. The closure is effective from Thursday, October 01, 2026, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the half-year ending September 30, 2026. This action is in accordance with Regulation 9 read with Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's Insider Trading Code. The date for the Board meeting to declare these financial results will be communicated in due course.

Cian Healthcare Limited has dispatched a letter to shareholders whose email addresses are not registered, providing a web-link to access the Notice of the 23rd Annual General Meeting and the Annual Report for the Financial Year 2025-26. The AGM is scheduled for September 29, 2026, via Video Conferencing. Physical copies of the Annual Report will not be dispatched unless specifically requested. Shareholders are urged to update their PAN, KYC, and nomination details to ensure timely payments like dividends and to comply with SEBI guidelines.

Cian Healthcare Limited has announced its 23rd Annual General Meeting (AGM) to be held on Tuesday, September 29, 2026, at 11:00 a.m. IST via Video Conferencing/Other Audio Visual Means. The board approved the AGM notice on September 2, 2026. Key agenda items include the adoption of audited standalone and consolidated financial statements for FY26, re-appointment of a director, appointment of statutory auditors M/s Rasool Singhal & Co. for a five-year term, filling a casual vacancy for auditors, and approval of the Employee Stock Option Scheme, 2026, including grants to group companies. E-voting facilities will be available from September 26 to September 28, 2026.

Cian Healthcare Limited has announced its 23rd Annual General Meeting (AGM) scheduled for September 29, 2026, at 11:00 a.m. IST, to be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM). The company is also releasing its Annual Report for the financial year ended March 31, 2026. Both the Annual Report and the AGM notice are being disseminated electronically to members with registered email IDs and will be available on the company's website and through its Registrar and Share Transfer Agent. Physical copies will be provided upon request, and alternative access methods are being provided to members whose email addresses are not registered.

Cian Healthcare Limited's Audit Committee met on September 02, 2026, to consider and note the resignation of M/s S S R C A & Co. as Statutory Auditors, effective August 27, 2026. The committee confirmed there were no concerns or qualifications leading to the resignation, and no material reasons beyond those stated in the resignation letter. The committee recommended these findings to the Board of Directors for their deliberation and noting. The meeting commenced at 01:00 P.M. IST and concluded at 01:53 P.M. IST.

Cian Healthcare Limited announced board resolutions passed on September 02, 2026, appointing M/s Rasool Singhal & Co. as Statutory Auditors to fill a casual vacancy caused by the resignation of M/s S S R C A & Co. The firm will hold office until the next Annual General Meeting. Additionally, M/s N D M & Company has been appointed as Internal Auditors for the financial year 2026-27, based on the Audit Committee's recommendation. Both appointments were made following SEBI regulations.

Cian Healthcare Limited announced that its statutory auditors, M/s. S S R C A & Co., have resigned from their position effective August 27, 2026. The resignation is attributed to professional commitments and pre-occupations of the auditors. The company will disclose the Audit Committee's views on this resignation in an upcoming meeting. The resignation letter confirms no material reasons beyond those stated. The company is also required to submit this disclosure in XBRL mode.

Cian Healthcare Ltd has announced a revision in its market lot size for equity shares, as approved by BSE Limited. Effective August 24, 2026, the market lot has been reduced from 2,000 shares to 137 shares. This change is in accordance with the Resolution Plan approved by the Hon'ble National Company Law Tribunal (NCLT) on December 18, 2025, and follows the trading approval granted by BSE. The company is complying with SEBI regulations and the NCLT order for this adjustment.

Cian Healthcare Limited's board approved audited standalone and consolidated financial results for the year ended March 31, 2026, during its meeting on May 30, 2026. The meeting, which commenced at 02:00 P.M. and concluded at 03:35 P.M. (1ST), also addressed the audit report with modified opinions. The company is under a resolution plan approved by NCLT, with management vested in a Resolution Plan Implementation Committee.

Cian Healthcare Limited announced the audited standalone and consolidated financial results for the half-year and financial year ended March 31, 2026. The Board of Directors approved the financial results at their meeting held on May 30, 2026. The meeting also noted the audit report with modified opinion issued by M/s S SR CA & Co., Chartered Accountants. The company is undergoing a Corporate Insolvency Resolution Process (CIRP) which was restored effective August 14, 2024. A resolution plan was approved by NCLT on December 18, 2025, for ₹37,30,13,553.